Tumour necrosis factor, interferon-gamma and interleukins as predictive markers of antiprogrammed cell-death protein-1 treatment in advanced non-small cell lung cancer: a pragmatic approach in clinical practice

BACKGROUND: The emergence of novel antiprogrammed cell death protein-1 (PD-1) inhibitors in non-small cell lung cancers (NSCLC) has revolutionized the therapeutic landscape of this disease. Although overall survival (OS) has improved in the first- and second-line therapy settings for advanced NSCLC,...

Descripción completa

Detalles Bibliográficos
Autores principales: Boutsikou, Efimia, Domvri, Kalliopi, Hardavella, Georgia, Tsiouda, Dora, Zarogoulidis, Konstantinos, Kontakiotis, Theodoros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894896/
https://www.ncbi.nlm.nih.gov/pubmed/29662549
http://dx.doi.org/10.1177/1758835918768238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894896/
https://www.ncbi.nlm.nih.gov/pubmed/29662549
http://dx.doi.org/10.1177/1758835918768238

Ejemplares similares